MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports
Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis
Abstract
The occurrence of tuberculosis among persons with human immunodeficiency virus (HIV) infection has prompted the development of guidelines for the management of those who may have both tuberculous and HIV infections (1). These guidelines include the recommendation that all persons who are known to be infected with HIV, or are at increased risk of HIV infection, receive a tuberculin skin test (Mantoux test with tuberculin units 5 [TU] of purified protein derivative [PPD]-tuberculin). Those persons who have at least a 5 mm reaction to PPD should be considered for 1 year of isoniazid preventive therapy, unless otherwise contraindicated.
Source and rights
Published by MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 1991. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 1991
- Applies to
- 🇪🇺 Europe
- Scope
- Regional
- Journal
- MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports
- PubMed
- 2034206
- Added to Prognia
- 16 July 2026